Rebecca Elizabeth Stockwell

Rebecca Elizabeth Stockwell

Auto-generated profile, based on publicly available information

Rebecca Elizabeth Stockwell

Lung Bacteria Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2016 in Science
Verified
Journal Article
Open access
PDF file
JBJosephine M. Bryant
Josephine M. Bryant
DGDorothy M. Grogono
Dorothy M. Grogono
DRDaniela Rodriguez-Rincon
Daniela Rodriguez-Rincon
IEIsobel Everall
Isobel Everall
KBKaren P. Brown
Karen P. Brown
RFR. Andres Floto
R. Andres Floto
Global spread of aggressive mycobacteria: Many mycobacteria, in addition to those causing leprosy and tuberculosis, are capable of infecting humans. Some can be particularly dangerous in patients suffering from immunosuppression or chronic disease, such as cystic fibrosis (CF). Bryant et al. observed clusters of near-identical isolates of drug-resistant Mycobacterium abscessus in patients reporting to CF clinics. The similarity of the isolates suggests transmission between patients, rather than environmental acquisition. Although this bacterium is renowned for its environmental resilience, the mechanism for its long-distance transmission among the global CF patient community remains a puzzle. Science , this issue p. 751

1 October 2019 in Journal of Hospital Infection
Verified
Journal Article
Closed access
RSR.E. Stockwell
R.E. Stockwell
EBE.L. Ballard
E.L. Ballard
POP. O'ROurke
P. O'ROurke
Knibbs LukeKnibbs Luke
Knibbs Luke
LMLidia Morawska
Lidia Morawska
SBS.C. Bell
S.C. Bell

1 February 2018 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
MWMichelle E. Wood
Michelle E. Wood
RSRebecca E. Stockwell
Rebecca E. Stockwell
GJGraham R. Johnson
Graham R. Johnson
KRKay A. Ramsay
Kay A. Ramsay
LSLaura J. Sherrard
Laura J. Sherrard
SBScott C. Bell
Scott C. Bell
Rationale: People with cystic fibrosis (CF) generate Pseudomonas aeruginosa in droplet nuclei during coughing. The use of surgical masks has been recommended in healthcare settings to minimize pathogen transmission between patients with CF. Objectives: To determine if face masks and cough etiquette reduce viable P. aeruginosa aerosolized during coughing. Methods: Twenty-five adults with CF and chronic P. aeruginosa infection were recruited. Participants performed six talking and coughing maneuvers, with or without face masks (surgical and N95) and hand covering the mouth when coughing (cough etiquette) in an aerosol-sampling device. An Andersen Cascade Impactor was used to sample the aerosol at 2 meters from each participant. Quantitative sputum and aerosol bacterial cultures were performed, and participants rated the mask comfort levels during the cough maneuvers. Measurements and Main Results: During uncovered coughing (reference maneuver), 19 of 25 (76%) participants produced aerosols containing P. aeruginosa, with a positive correlation found between sputum P. aeruginosa concentration (measured as cfu/ml) and aerosol P. aeruginosa colony-forming units. There was a reduction in aerosol P. aeruginosa load during coughing with a surgical mask, coughing with an N95 mask, and cough etiquette compared with uncovered coughing (P < 0.001). A similar reduction in total colony-forming units was observed for both masks during coughing; yet, participants rated the surgical masks as more comfortable (P = 0.013). Cough etiquette provided approximately half the reduction of viable aerosols of the mask interventions during voluntary coughing. Talking was a low viable aerosol–producing activity. Conclusions: Face masks reduce cough-generated P. aeruginosa aerosols, with the surgical mask providing enhanced comfort. Cough etiquette was less effective at reducing viable aerosols.

1 October 2017 in Environment International
Verified
Journal Article
Closed access
CHCongrong He
Congrong He
IMIan M. Mackay
Ian M. Mackay
KRKay Annette Ramsay
Kay Annette Ramsay
ZLZhen Liang
Zhen Liang
TKTimothy Kidd
Timothy Kidd
LMLidia Morawska
Lidia Morawska

15 November 2018 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
RSRebecca E. Stockwell
Rebecca E. Stockwell
MWMichelle E. Wood
Michelle E. Wood
CHCongrong He
Congrong He
LSLaura J. Sherrard
Laura J. Sherrard
EBEmma L. Ballard
Emma L. Ballard
SBScott C. Bell
Scott C. Bell

28 March 2016 in Expert Review of Respiratory Medicine
Verified
Journal Article
Closed access
KRKa Ramsay
Ka Ramsay
RSRe Stockwell
Re Stockwell
SBSc Bell
Sc Bell
TKTj Kidd
Tj Kidd
In many countries numbers of adults with cystic fibrosis (CF) exceed that of children, with median survival predicted to surpass 50 years. Increasing longevity is, in part, due to intensive therapies including eradication of early infection and suppressive therapies and pulmonary exacerbations. Initial infections with common CF pathogens are thought to arise from the natural environment. We review the impact of climate and environment on infection in CF Specifically, several studies indicate that higher ambient temperatures, proximity to the equator and the summer season may be linked to the increased prevalence of P. aeruginosa in people with CF. The environment may also play an important role in the acquisition of Gram negative organisms other than P. aeruginosa. There is emerging data suggesting that climatic and environmental factors are likely to impact on the risk of infection with NTM and fungi in people which are found extensively throughout the natural environment.